ZSCAN26 |
Q16670
|
zinc finger and SCAN domain containing 26
|
|
|
0.931 |
0.115 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
FCGR2C |
P31995
|
Fc fragment of IgG receptor IIc (gene/pseudogene)
|
Cell adhesion
|
|
0.610 |
0.654 |
HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
IGKV3-20 |
P01619
|
immunoglobulin kappa variable 3-20
|
Immune response
|
|
0.736 |
0.308 |
MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
IBD5 |
|
inflammatory bowel disease 5
|
|
|
0.705 |
0.538 |
KIR2DL5A |
Q8N109
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
|
Receptor
|
|
0.711 |
0.423 |
IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
BMS1P20 |
|
BMS1 pseudogene 20
|
|
|
0.682 |
0.577 |
DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |